Recruiting MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225 Conditions Accelerated Phase MPN, Accelerated Phase Myeloproliferative Neoplasm, Agnogenic Myeloid Metaplasia, +78 more Locations MPN Research Foundation — Chicago, Illinois, United States Memorial Sloan Kettering Cancer Center — New York, United States View Trial Details
Completed Dasatinib as Therapy for Myeloproliferative Disorders (MPDs) NCT00255346 Conditions Acute Myeloid Leukemia, Agnogenic Myeloid Metaplasia, Bone Marrow Diseases, +29 more Locations The University of Texas M.D. Anderson Cancer Center — Houston, Texas, United States View Trial Details
Completed A Study of Gleevec in Patients With Idiopathic Myelofibrosis or Chronic Myelomonocytic Leukemia (CMML) NCT00136409 Conditions Agnogenic Myeloid Metaplasia, Bone Marrow Diseases, Chronic Disease, +16 more Locations Dana-Farber Cancer Institute — Boston, Massachusetts, United States Massachusetts General Hospital — Boston, Massachusetts, United States View Trial Details
Completed PTK 787 and Gleevec in Patients With AML, AMM, and CML-BP NCT00088231 Conditions Acute Myelogenous Leukemia, Agnogenic Myeloid Metaplasia, Blast Crisis, +19 more Locations M.D. Anderson Cancer Center — Houston, Texas, United States View Trial Details
Completed A Phase 1 Study of MKC-1 in Patients With Refractory Hematologic Malignancies NCT00506402 Conditions Agnogenic Myeloid Metaplasia, Anemia, Anemia, Refractory, +12 more Locations Princess Margaret Hospital — Toronto, Canada View Trial Details
